MISSISSAUGA, Ontario,
Nov. 30, 2016 /CNW/ -- Aralez
Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global
specialty pharmaceutical company, today announced that
Adrian Adams, Chief Executive
Officer, will participate in the following healthcare
conferences:
- Guggenheim's One-on-One Healthcare Conference in Boston on Tuesday,
December 13, 2016
- BMO Healthcare Conference in New
York on Wednesday, December 14,
2016 at 11:00 a.m.
A live webcast and audio archive for the BMO event may be
accessed from the Investors section of the Aralez website at
www.aralez.com. Please connect to the website prior to the start of
the presentation to ensure adequate time for any software downloads
that may be necessary to listen to the webcast.
About Aralez Pharmaceuticals Inc.
Aralez
Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global
specialty pharmaceutical company focused on delivering meaningful
products to improve patients' lives while creating shareholder
value by acquiring, developing and commercializing products
primarily in cardiovascular, pain and other specialty areas.
Aralez's Global Headquarters is in Ontario, Canada, the US Headquarters is
planned to be in Princeton, NJ and
the Ireland Headquarters is in Dublin,
Ireland. More information about Aralez can be found at
www.aralez.com.
Contact Information:
Aralez Pharmaceuticals US
Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications
732.754.2545
nochsner@aralez.com
Logo - http://photos.prnewswire.com/prnh/20161001/414159LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aralez-to-participate-at-two-upcoming-healthcare-conferences-300370071.html
SOURCE Aralez Pharmaceuticals Inc.